Healthcare expenditure projections up to 2045

Braendle, Thomas and Colombier, Carsten (2017): Healthcare expenditure projections up to 2045. Published in: Healthcare expenditure and fiscal sustainability: evidence from Switzerland , Vol. 42, No. 3 (2018): pp. 279-301.

Abstract

These projections show that demographic change will have a significant impact on the dynamism of healthcare expenditure. The effect of an ageing population is most significant in the area of long-term care. For healthcare excluding long-term care, non-demographic cost drivers – such as the Baumol effect and determinants captured indirectly by income elasticity such as advances in medical technology and market failures as a result of asymmetric information – are likewise very significant. As the key player in this area, (acting not just as regulator, but also as a source of financing and service provider), it is the cantons that will have to bear the main burden of rising healthcare expenditure. In addition, the public sector will be more heavily affected by an ageing population than OKP, as the general government sector spends a greater proportion of its funds on long-term care than OKP. The projections provide the following pointers for the orientation of healthcare policy. On the one hand, measures should be promoted that sustainably alleviate the illness burden on the population, particularly in the case of chronic conditions, thereby facilitating healthy ageing. The focus here should be on strengthening healthcare skills and promoting healthy lifestyles by means of adequate preventive measures. On the other hand, existing efficiency reserves need to be better exploited by avoiding unnecessary treatments, incorporating cost-benefit considerations more strongly into the design of the OKP service catalogue (health technology assessment), and ensuring that the increasing productivity of medical services is appropriately reflected in the corresponding prices and tariffs. While the new DRG flat-rate payments per case should contribute to reducing misplaced incentives and strengthening competition in the inpatient area, the obsolete fee-for-service remuneration system in the outpatient area generally contains an oversupply incentive, particularly in the case of technical services. A strengthening of Spitex and the improved compatibility of professional life and family-based care would also help to reduce the length of the average care home stay. Finally, the next two decades will see an increase in demand for healthcare and nursing care staff, which will make forward-looking personnel planning and an improvement of working processes more necessary than ever.

• Item Type: MPRA Paper
• Language: English
• Keywords: healthcare expenditure, long-term care expenditure,population ageing, fiscal sustainability, mandatory health insurance (OKP), public HCE, Baumol's cost disease, medical-technical progress, income effect
• Subjects: H - Public Economics > H5 - National Government Expenditures and Related Policies > H51 - Government Expenditures and Health; I - Health, Education, and Welfare > I1 - Health > I13 - Health Insurance, Public and Private; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health

References

Acemoglu, D., Finkelstein, A. und Notowidigdo, M. (2013). Income and Health Spending: Evidence from Oil Price Shocks, Review of Economics and Statistics, 95(4), 1079-1095.

AWG; Ageing Working Group of the Economic Policy Committee und European Commission (2015). The 2015 Ageing Report, European Economy, 03/2015.

Baltagi, B. H. und Moscone, F. (2010). Health Care Expenditure and Income in the OECD Reconsidered: Evidence from Panel Data. Economic Modelling, 27(4), 804-811.

Baumol, W. J. (1967). Macroeconomics of Unbalanced Growth: The Anatomy of Urban Crisis, American Economic Review, 57(3), 415-26.

Braendle, T. und Colombier, C (2016). What Drives Public Health Care Expenditure Growth? Evidence from Swiss Cantons, 1970-2012, Health Policy, 120(9), 1051–1060.

Breyer, F., Lorenz, N., und Niebel, Th. (2015). Health Care Expenditures and Longevity: Is There a Eubie Blake Effect? European Journal of Health Economics, 16, 95–112.

Breyer, F. und Felder, S. (2006). Life Expectancy and Health Care Expenditures: A New Calculation for Germany Using the Costs of Dying. Health Policy, 75(2), 178-186.

Bates, L. J., und Santerre, R. E. (2013). Does the US Health Care Sector Suffer From Baumol's Cost Disease? Evidence from the 50 States, Journal of Health Economics, 32(2), 386-391.

Bundesamt für Statistik (2016). Kosten des Gesundheitswesens seit 1960, Neuchâtel.

Bundesamt für Statistik (2015a). Szenarien zur Bevölkerungsentwicklung der Schweiz 2015–2045, Neuchâtel.

Bundesamt für Statistik (2015b). Kosten und Finanzierung des Gesundheitswesens nach Leistungen und Finanzierungsregimes 2013.

Bundesrat (2012). Entwicklungsszenarien für das Gesundheitswesen. In: Legislaturfinanzplan 2013-15, Abschnitt 9.1.2. und Anhang 7.

Bundesrat (2016). Bestandesaufnahme und Perspektiven im Bereich der Langzeitpflege, Bericht des Bundesrates in Erfüllung der Postulate 12.3604 Fehr Jacqueline vom 15. Juni 2012; 14.3912 Eder vom 25. September 2014 und 14.4165 Lehmann vom 11. Dezember 2014, Mai 2016, Bern.

Colombier, C. (2017). Drivers of Health Care Expenditure: What Role Does Baumol’s Cost Play? Forthcoming in Social Sciences Quarterly.

Colombier, C. (2016). Population Aging in Healthcare – A Minor Issue? FiFo Discussion Paper No. 16-3, Finanzwissenschaftliches Forschungsinstitut an der Universität zu Köln.

Colombier, C. (2012). Ausgabenprojektionen für das Gesundheitswesen bis 2060, Working Paper der EFV Nr. 19, Bern.

Colombier, C., und Weber, W. (2011). Projecting Health-care Expenditure for Switzerland: Further Evidence against the ‘Red-herring’ Hypothesis. The International Journal of Health Planning and Management, 26, 245–263.

Colombier, C. und Weber, W. (2008). Ausgabenprojektionen für das Gesundheitswesen bis 2050, Working Paper der EFV Nr. 10, Eidgenössische Finanzverwaltung (EFV), Bern.

Costa-Font, J., Gemmill, M. und Rubert, G. (2011). Biases in the Healthcare Luxury Good Hypothesis?: A Meta-Regression Analysis, Journal of the Royal Statistical Society, 174(1), 95–107.

Credit Suisse (2013). Gesundheitswesen Schweiz 2013: Der Spitalmarkt im Wandel. Swiss Issues Branchen, August 2013, Zürich.

Credit Suisse (2015). Gesundheitswesen Schweiz 2015 – Die Zukunft des Pflegeheimmarkts, Swiss Issues Branchen, Juni 2015, Investment Strategy & Research, Economic Research, Zürich.

Crivelli, L., Filippini M. und Mosca, I. (2006). Federalism and Regional Healthcare Expenditure: An Empirical Analysis for the Swiss Cantons. Health Economics Letters, 15(5), 535-541.

De la Maisonneuve, C., Oliveira Martins, J. (2014). The Future of Health and Long-Term Care Spending, OECD Journal: Economic Studies, 2014(1): 61-96.

Eidgenössisches Finanzdepartment (2016). Langfristperspektiven der öffentlichen Finanzen in der Schweiz 2016, Bern: Eidgenössische Finanzverwaltung.

Eidgenössische Finanzverwaltung (2015). Finanzstatistik der Schweiz 2013. Jahresbericht.

Felder, S. (2013). Managing the Healthcare System: The Impact of Demographic Change on Healthcare Expenditure, CESifo DICE Report 1/2013, 3-6.

Fries, J.F. (1980). Ageing, Natural Death, and the Compression of Morbidity, The New England Journal of Medicine, 303(3), 130-135.

Fries, J.F. (1989). The Compression of Morbidity: Near or Far?, Milbank Memorial Fund Quarterly, 67(2), 208-232.

Gruenberg, E.M. (1977). The Failure of Success, Milbank Memorial Fund Quarterly, 55(1), 3- 24.

Gerdtham, U.G. und Jönsson, B. (2000). International Comparisons of Health Expenditure: Theory, Data and Econometric Analysis. In: Cuyler, A.J., Newhouse, J.P. (eds.). Handbook of Health Economics, Elsevier Science, North Holland, 11-53.

Glied, S. und Smith, P. (2013). The Oxford Handbook of Health Economics. Oxford University Press.

Gregersen, F. (2014). The Impact of Ageing on Health Care Expenditure: A Study of Steepening. European Journal of Health Economics, 15, 979–989.

Hartwig, J. (2008). What Drives Health Care Expenditure? - Baumol’s Model of Unbalanced Growth Revisited. Journal of Health Economics, 27(3), 603–23.

Hartwig, J. und Sturm, J.E. (2014). Robust Determinants of Health Care Expenditure Growth. Applied Economics, 46(36), 4455-4474.

Hsiao, W. und Heller, P.S. (2007). What Should Macroeconomists Know about Health Care Policy? IMF Working Paper No. 07/13.

Jaccard, R. H. und Weaver, F. (2009). Ageing Workforce in an Ageing Society – Wie viele Health Professionals braucht das Schweizer Gesundheitssystem bis 2030? Careum Working Paper Nr. 1, Schweizerisches Gesundheitsobservatorium.

Polder, J.J., Barendregt, J. und van Oers, H. (2006). Health Care Costs in the Last Year of Life - The Dutch Experience, Social Science and Medicine, 63(7), 1720-1731.

Manton K.G. (1982). Changing Concepts of Morbidity and Mortality in the Elderly Population, Milbank Memorial Fund Quarterly, 60(2), 183-244.

Martin, J.J., M., del Amo Gonzalez, M.P.L. und Garcia, D. C. (2011). Review of the Literature on the Determinants of Healthcare Expenditure. Applied Economics, 43(1), 19-46.

Medeiros J. und Schwierz, C. (2013). Estimating the Drivers and Projecting Long-term Public health expenditure in the European Union: Baumol's 'cost disease' revisited", European Economy, Economic Papers No. 507.

Moog, S., Raffelhüschen, B. und Weisser, V. (2014). Altersvorsorge und die Schweizer Generationenbilanz – Lasten in die Zukunft verschoben. UBS, Zürich.

Moscone, F. und Tosetti, E. (2010). Health Expenditures and Income in the United States. Health Economics, 19, 1385-1403.

Reich, O., Weins, C., Schusterschnitz, C. und Thöni, M. (2012). Exploring the Disparities of Regional Healthcare Expenditures in Switzerland: Some Empirical Evidence. European Journal of Health Economics, 13, 193-202.

Rice, Th. (2003). The Economics of Health Reconsidered, Health Administration Press, Chicago.

Smith, S.D., Newhouse, J.P., und M.S. Freeland (2009). Income, Insurance, and Technology: Why Does Health Spending Outpace Economic Growth? Health Affairs, 28(5), 1276–1284.

Stearns, S.C. und Norton, C. (2004). Time to Include Time to Death? The Future of Health Care Expenditure Projections, Health Economics, 13(4), 315-327.

Suhrcke, M., McKee, M., Stuckler, D., Sauto Arce, R., Tsolova, S. und Mortensen, J. (2006). The Contribution of Health to the Economy in the Eurpean Union, Public Health, 120, 994-1001.

Van Baal, P.H. und Wong, A. (2012). Time to Death and the Forecast of Macro-level Health Care Expenditure: Some Further Considerations. Journal of Health Economics, 31, 876–887.

Vatter, A. und Ruefli, C. (2003). Do Political Factors Matter for Healthcare Expenditure? A Comparative Study of Swiss Cantons. Journal of Public Policy, 23(3), 301-323.

Weaver, F., Jaccard, R. H., Pelligrini, S. und Jeanrenaud, C. (2008). Les couts des soins de longue durée d’ici à 2030 en Suisse. OBSAN, Neuchâtel.

Zweifel, P., Felder, S. und Meiers, M. (1999). Ageing of Population and Health Care Expenditure: A Red Herring?” Health Economics, 8(6), 485-96.